specific cell surface receptors to control axon guidance. These guidance factors function as either attractive or repulsive guidance cues depending on their ability to induce growth cone extension or retraction. The directional control of axon pathfinding is thought to result The control of axon guidance by Eph receptors is and Rac1 inhibition, and cell morphology changes. In of individual Rho GTPases.
The molecular mechanisms by which EphA receptors nucleotide 156. More recently, a partial cDNA encoding mouse ephexin, called Ngef, was identified and was and other axon guidance receptors regulate the activity of Rho family GTPases remain to be elucidated. It is demonstrated to reside on human chromosome 2q37 and mouse chromosome 1 (Rodrigues et al., 2000). known that Rho GTPases function as binary molecular switches, shuttling between an inactive GDP bound conConceptual translation of the mouse cDNA revealed a protein of 620 amino acids comprising an N-terminal formation and an active GTP bound conformation, in which the Rho GTPases bind and activate downstream region with no homology to other proteins, a tandem Dbl homology-pleckstrin homology (DH-PH) motif that effectors. Rho GTPases are regulated by the opposing effects of two classes of enzymes, guanine nucleotide is conserved in all Dbl GEFs, and a C-terminal SH3 domain ( Figure 1A ). Immunoblotting with affinity-puriexchange factors (GEFs) of the Dbl family and GTPaseactivating proteins (GAPs). Dbl GEFs act to enhance the fied polyclonal antibodies raised against either the N-terminal region, the SH3 domain, or the C-terminal exchange of bound GDP for GTP and thus activate the Rho GTPases, whereas GAPs inhibit Rho family memtail of ephexin detected an endogenous protein present in rat telencephalic neurons ( Figure 1B ) that displayed bers by potentiating their intrinsic GTPase activity. One intriguing possibility is that the activity of Dbl GEFs the same electrophoretic mobility as recombinant murine ephexin expressed in 293T cells (data not shown). and/or GAPs might be regulated by cell surface receptors so as to link extracellular axon guidance cues to Partial V8 proteolysis of lysates from neurons and ephexin-expressing 293T cells followed by immunoblothighly localized changes in the actin cytoskeleton within a growth cone.
ting with the C-terminal anti-ephexin antibody confirmed that the recombinant and endogenous proteins are idenHere we report the cloning and characterization of ephexin, a novel member of the Dbl family of GEFs that tical (data not shown). Taken together, these data indicate that the murine ephexin clone includes the fullinteracts directly with EphA4. In the absence of ephrin-A stimulation, ephexin catalyzes guanine nucleotide exlength ephexin coding sequence. The initiator methionine of ephexin is followed by a change for RhoA, Cdc42, and Rac1. The activation of EphA receptors inhibits ephexin activity toward Cdc42 hydrophobic stretch of 14 amino acids resembling a signal peptide or a signal-anchor sequence (Martoglio and Rac1, yet potentiates its activity toward RhoA. An inhibitory mutant of ephexin suppresses ephrin-A1-and Dobberstein, 1998). We have been unable to detect endogenous or overexpressed rat ephexin in a secreted induced growth cone collapse in purified RGCs, suggesting an important role for ephexin in EphA regulation form, and the hydrophobic sequence is not predicted to be a signal peptide by an algorithm designed to recogof growth cone motility. We propose that spatially restricted regulation of Rho GTPase signaling pathways nize signal peptides (Emanuelsson et al., 2000) . Instead, this hydrophobic region may serve as a signal-anchor through the modulation of ephexin activity may underlie localized growth cone responses to ephrin-A.
sequence to localize ephexin to the inner surface of the plasma membrane (Wahlberg and Spiess, 1997 regions, including the 14 amino acid hydrophobic seother ages to determine if ephexin expression is developmentally regulated. Ephexin mRNA can first be detected quence present in ephexin orthologs ( Figure 1D ). in E15 rat brain and gradually increases throughout embryonic development (Figure 2A ). In the early postnatal Ephexin Expression Is Enriched in the Nervous period, ephexin mRNA levels rise sharply, peak at P10, System and Is Developmentally Regulated and then decline. Interestingly, this expression pattern We determined the tissue distribution of ephexin to gain closely matches that previously described for EphA4 insight into possible functional roles for this GEF. North- (Mori et al., 1995) . Ephexin mRNA expression in the E17 ern blot analysis of ephexin mRNA from P20 rat tissues rat was found by in situ hybridization to be restricted to revealed an approximately 2.8 kb mRNA species with the eye and also in deep layers of the developing cortex highest levels of expression in the brain and spinal cord ( Figure 2B ). In the eye, ephexin expression was diffuse and lower levels of expression in testes (Figure 2A ). In at E17 and then became highly restricted to the inner addition, we detected low levels of a transcript in kidney nuclear and RGC layers at P6 ( Figure 2C ). Staining of and liver that migrates more slowly than the neuronal control and ephexin-transfected P6 RGCs with the affintranscripts. These more slowly migrating transcripts may ity-purified polyclonal anti-ephexin N-terminal antibody represent alternatively spliced or initiated ephexin mRNA (anti-ephexinN) revealed that endogenous and overexor a closely related family member. Ephexin mRNA was pressed ephexin protein is localized in RGC axonal not detected in heart, lung, skeletal muscle, or spleen. growth cones ( Figure 2D ). Since the topographic mapThe enrichment of ephexin mRNA in the nervous sysping of RGC axons to CNS targets in the early postnatal stages of development is regulated by EphA receptors in tem at P20 led us to explore its expression in brain at Since ephexin has strong GEF activity toward different The ephexin DH, PH, or SH3 domains alone were unable Rho family members, we investigated whether effector to bind EphA4 in the two-hybrid assay ( Figure 3C ). Howenzymes downstream of Rho GTPases might also be ever, the tandem ephexin DH-PH domains were suffiinduced in response to ephexin activation. Several lines cient to mediate an interaction with EphA4, suggesting of evidence link activation of the Rac1 and Cdc42 efthat portions of both domains are important for the interfector Pak to modifications in the organization of the action of ephexin with EphA4 ( Figure 3C activity of endogenous ephexin, we incorporated the of evidence suggest that ephexin couples EphA receptor Q254A mutation into the DH-PH module of ephexin (QAactivation to modulation of Rho GTPase signaling that DH-PH) and overexpressed it in RGCs. Since the GEFleads to growth cone collapse. First, ephexin is expressed inactive QA-DH-PH mutant maintains EphA4 receptor specifically in the CNS and is present during embryonic binding activity (data not shown) and lacks the ability development in regions of the nervous system where to bind to potentially important SH3 binding coregulaEphA receptors function to control axon guidance. Sectors, this mutant could uncouple endogenous ephexin ond, ephexin associates directly with EphA receptors. from EphA receptor regulation. When expressed in RGCs, Third, the activation of EphA receptors potentiates the QA-DH-PH significantly inhibited ephrin-A1-induced ability of ephexin to activate RhoA yet leads to an inhibigrowth cone collapse (Figures 6C and 6D) . The exprestion of ephexin activity toward Cdc42 and Rac1. Finally, sion of wild-type or mutant ephexins did not significantly overexpression of ephexin leads to increased sensitivity alter basal rates of collapse in unstimulated RGCs (data of RGCs to ephrin-A1-induced growth cone collapse, not shown), demonstrating that the changes in collapse whereas a dominant-negative version of ephexin suprates were dependent on EphA receptor activity. Taken 
